Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. (Q53840262)
Jump to navigation
Jump to search
scientific article
- Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. |
scientific article |
|
Statements
Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. (English)
1 reference
Bin Gui
1 reference
Ashley A Weiner
1 reference
John Nosher
1 reference
Shou-En Lu
1 reference
Gretchen M Foltz
1 reference
Omar Hasan
1 reference
Seung K Kim
1 reference
Vyacheslav Gendel
1 reference
Naganathan B Mani
1 reference
Darren R Carpizo
1 reference
Nael E Saad
1 reference
Timothy J Kennedy
1 reference
Darryl A Zuckerman
1 reference
Jeffrey R Olsen
1 reference
Parag J Parikh
1 reference
Salma K Jabbour
1 reference
17 April 2017
1 reference
41
0 references
9
0 references
861-866
0 references
Identifiers
1 reference